New user? Sign up here |

HIV Resistance, Liver Disease & New Therapy

Details

Center for Infectious Diseases Management and Research
2139 Georgia Ave, NW Washington, DC
Starts at: November 19, 2020 10:00am ET
Ends at: November 19, 2020 11:00am ET
Free Admission
Get Driving Directions

Description

Patient with M184V, K103N (from 9/2020), with liver disease (Fibrosure now F4), patient taking Descovy + Efavirenz - need for adjustment in therapy. Adjustment to therapy, Child Pugh score, renal function discussed and potential therapy options reviewed for interactions. 

Also, induction capability of Efavirenz with discontinuation need to to keep NRTIs on board during adjustment. 

 

 

Targeted Populations

A variety of the listed populations will be discussed at this event.

  • Black or African American

Topics

A variety of the listed topics will be discussed at this event.

  • Aging and HIV
  • Antiretroviral treatment adherence, including viral load suppression
  • HIV monitoring and lab tests (i.e. CD4 ad viral load)
  • HIV resistance testing and interpretation
  • Hepatitis C
  • Opportunistic Infections
  • Care coordination